Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Profarma Logo
Profarma Growth Score
79
CB Rank
1441851
Heat Score
44
Profarma is a pharmaceutical wholesaler in Brazil.
Founded
obfuscation
PublicPost-IPO Equity Barra Da Tijuca, Rio de Janeiro, Brazil1001-5000 www.profarma.com.br
Pharmaceutical
Overview

Profarma
Growth Score
79
Heat Score
44

Growth Score79
-9 pts
in past quarter
Heat Score 44
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
See more interactive data and historical milestones on desktop for the best experience

About Profarma

CB Rank
1441851
Profarma is a pharmaceutical wholesaler in Brazil.
Founded
obfuscation
PublicPost-IPO Equity Barra Da Tijuca, Rio de Janeiro, Brazil1001-5000 www.profarma.com.br
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Details

Also Known As Profarma Distribuidora de Produtos Farmaceuticos SA
Operating Status Active
Stock Symbol  BVMF:PFRM3
Company Type For Profit
About the Company

Profarma has been engaged for 52 years in the distribution of pharmaceuticals, personal care products and cosmetics. The company provides medicines, personal care, health and beauty care, oncological, and dermatological products; and toiletries, vaccines, prostheses, and hormones in the South, Southeast, Northeast, and Center-West regions of

Brazil.

Phone Number +552140090200
Predictions & Insights

Products & Services

Pharmaceutical Wholesale Distribution
Distribution of pharmaceutical products to pharmacies and healthcare providers across Brazil.
Electronic Ordering System (Novo Pedido Eletrônico)
An electronic platform for customers to place and track pharmaceutical product orders.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity

Funding Rounds

Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
1
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Cencora Logo
Cencora
No
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
—
Cencora Logo
Cencora
No
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
—
Cencora Logo
Cencora
No
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
—
Cencora Logo
Cencora
No
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
—
Cencora Logo
Cencora
No
Post-IPO Equity - Profarma Logo
Post-IPO Equity - Profarma
—

Investments

Number of Acquisitions 1

Investment Breakdown

Number of Acquisitions 1
Market Intelligence
People
View Profiles & Contacts
Headcount 1001-5000 Contacts 33
News
Technology
View Tech Report

Monthly Web Visits

590,046
-5.35%
 in past month

Interest Signals

TopicSurge Score
AWS Security Logo
AWS Security
98
Joiner Mover Leaver Automation Logo
Joiner Mover Leaver Automation
91
Identity Compliance Management Logo
Identity Compliance Management
90

Actively Used Products

11Profarma uses 11 technology products and services including HTML5, Google Analytics, and  jQuery, according to G2 Stack.

Active Website Tech Count

31Profarma is actively using 31 technologies for its website, according to BuiltWith. These include DNSSEC, IPv6, and  Cloudflare JS.
Sub-Organizations

Sub-Organizations

Number of Sub-Orgs 1
Which industries do these Sub-Organization operate in?
Health Ventures Logo
Health VenturesDivision
Frequently Asked Questions

Where is Profarma's headquarters? Profarma is located in Barra Da Tijuca, Rio de Janeiro, Brazil.Who invested in Profarma? Profarma is funded by Cencora.When was the last funding round for Profarma? Profarma closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Profarma's competitors? Alternatives and possible competitors to Profarma may include Cotefácil, SantaCruz, and  Rede Grupofarma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|